Drug or treatment
Zasocitinib clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Zasocitinib that are recruiting, at sites in 24 countries (most in Germany (3), Poland (3), Spain (3)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 24Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Zasocitinib (TAK-279) in adults with active Crohn’s disease | Phase 2 | Oxford | Recruiting | Feb 11, 2026 |
| Continued daily zasocitinib treatment for adults with psoriatic arthritis | Phase 3 | Tucson, Arizona and 77 other locations | Recruiting | Dec 16, 2025 |
| Long-term zasocitinib treatment for children and teenagers with plaque psoriasis | Phase 3 | Chula Vista, California and 38 other locations | Recruiting | Nov 26, 2025 |
| Testing Zasocitinib for Psoriatic Arthritis in Adults | Phase 3 | Chandler, Arizona and 187 other locations | Recruiting | Nov 4, 2024 |
All recruiting trials (4)
-
Zasocitinib (TAK-279) in adults with active Crohn’s disease
This study tests zasocitinib in adults with Crohn’s disease to see if it can reveal how the drug works in the gut and whether it is safe.
-
Continued daily zasocitinib treatment for adults with psoriatic arthritis
This extension will try daily zasocitinib in adults with psoriatic arthritis who completed a year of earlier treatment to see how well it works and how safe it is over about two years.
-
Long-term zasocitinib treatment for children and teenagers with plaque psoriasis
This long-term study will see if the medicine zasocitinib is safe and helps children and teenagers (ages 4 to under 18) with moderate-to-severe plaque psoriasis.
-
Testing Zasocitinib for Psoriatic Arthritis in Adults
This study is testing a new medication called zasocitinib to see if it can help adults with active psoriatic arthritis who haven't tried biologic treatments before.
Quick answers
How many clinical trials of Zasocitinib are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 24 countries. The most sites are in Germany (3 trials), Poland (3 trials), Spain (3 trials), United States (3 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.